Upadhyay Suketu 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Apr 17, 2025
Insider Transaction Report
Form 4
Upadhyay Suketu
Director
Transactions
- Award
Deferred Stock Units
2025-04-15$497.51/sh+71.607$35,625→ 1,474.603 total→ Common Stock (71.607 underlying)
Footnotes (1)
- [F1]Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.